Save
Email
Print
Share
RSSBrowse News Stories
31 to 40 of 304 stories
view headlines only
-
Critical Tumor Suppressor for Cancer Identified
August 2, 2012 — Scientists have identified a protein that impairs the development and maintenance of lymphoma (cancer of the lymph nodes), but is repressed during the initial stages of the disease, allowing for ... > full story -
First Genome-Wide Analysis of Peripheral T-Cell Lymphomas
August 1, 2012 — Scientists have identified 13 novel alterations in aggressive blood ... > full story -
Potential Key to New Treatment for Mantle Cell Lymphoma (MCL)
July 18, 2012 — Researchers have demonstrated that the inhibition of signal transducer and activator of transcription 3 (STAT3) in mouse models of mantle cell lymphoma (MCL), an aggressive and incurable subtype of ... > full story -
New Drug Dramatically Improves Survival in Hodgkin Lymphoma Patients
June 27, 2012 — A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of ... > full story -
Progress in Quest to Reduce Use of Radiation in Treatment of Pediatric Hodgkin Lymphoma
June 27, 2012 — A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at ... > full story -
Type 2 Diabetes Linked to Increased Blood Cancer Risk
June 5, 2012 — A new meta-analysis reveals patients with type 2 diabetes have a 20 percent increased risk of developing blood ... > full story -
Children With Cancer Have Complete Responses in a COG Phase 1 Trial: Pills Zero in on Abnormal Genes That Drive Specific Cancers
May 16, 2012 — A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children ... > full story -
Exhaustion Renders Immune Cells Less Effective in Cancer Treatment
May 9, 2012 — Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to ... > full story -
Protein May Represent a Switch to Turn Off B Cell Lymphoma
May 7, 2012 — Researchers studying molecular signals that drive B cell lymphoma have found a key biological pathway leading to this type of cancer. The finding may help to break so-called "oncogene addiction" in ... > full story -
New Compound Targets Key Mechanism Behind Lymphoma
April 3, 2012 — Scientists have come one step closer to developing the first treatment to target a key pathway in ... > full story
Search ScienceDaily
Number of stories in archives: 137,119
more 
